Subsequent analysis of corresponding BCP-ALL patient data demonstrated aberrant expression of three TALE-class members especially in particular subtypes of BCP-ALL: IRX2 in subtype TCF3, IRX3 in subtype ETV6, and MEIS1 in subtype KMT2A. Here, IRX2 is linked to acute lymphoblastic leukemia.